FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceuticals and concerns a therapeutic agent for improvement of skin properties containing a compound of formula 
(I): as an active ingredient.
EFFECT: invention provides a medical product effective for prevented dry skin, reduced skin roughness and skin darkening associated with hyperkeratosis ensured by skin moisture preservation, and effective for impaired skin functions for the various reasons.
3 cl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITION OF DERMAL MEDICATION FOR EXTERNAL APPLICATION | 2010 |
|
RU2572694C2 |
| THERAPEUTICAL OR PREVENTIVE MEANS FOR DISEASES OF BILIARY TRACTS | 2011 |
|
RU2554857C2 |
| THERAPEUTIC OR PROPHYLACTIC AGENT FOR TREATING OR PREVENTING CACHEXIA | 2020 |
|
RU2825649C1 |
| THERAPEUTIC AGENT FOR TREATING RHINITIS | 2010 |
|
RU2502519C2 |
| MEDICINAL AGENT AND FOODSTUFF OR BEVERAGE FOR DECREASING HYPERGLYCEMIA | 2005 |
|
RU2315601C1 |
| DRUG FOR PREVENTION OR TREATMENT OF BRAIN ATROPHY | 2018 |
|
RU2759727C2 |
| TOPICAL AGENT FOR ACNE | 2014 |
|
RU2560698C1 |
| THERAPEUTIC AGENT FOR BILIARY TRACT CANCER TREATMENT | 2016 |
|
RU2728932C2 |
| METHOD FOR EVALUATING EFFICACY OF COMPOSITION FOR REDUCING EFFECT OF ANTICANCER THERAPEUTIC AGENTS ON SKIN | 2020 |
|
RU2829863C1 |
| NEW PREVENTIVE AND/OR THERAPEUTIC AGENT FOR NEUROPATHIC PAIN | 2008 |
|
RU2462459C2 |
